EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease

Joanna Batko iD, Katarzyna Antosz iD, Weronika Miśków iD, Magdalena Pszczołowska iD, Kamil Walczak, Jerzy Leszek

International Journal of Molecular Sciences · 17.03.2024 · 25 (6) · 3401

DOI: 10.3390/ijms25063401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.03.2024. Verfasst von Joanna Batko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, Poland. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The review describes correlations between impaired functioning of chaperones and co-chaperones in Alzheimer’s disease (AD) pathogenesis. The study aims to highlight significant lines of research in this field. Chaperones like Hsp90 or Hsp70 are critical agents in regulating cell homeostasis. Due to some conditions, like aging, their activity is damaged, resulting in β-amyloid and tau aggregation. This leads to the development of neurocognitive impairment. Dysregulation of co-chaperones is one of the causes of this condition. Disorders in the functioning of molecules like PP5, Cdc37, CacyBP/SIPTRAP1, CHIP protein, FKBP52, or STIP1 play a key role in AD pathogenesis. PP5, Cdc37, CacyBP/SIPTRAP1, and FKBP52 are Hsp90 co-chaperones. CHIP protein is a co-chaperone that switches Hsp70/Hsp90 complexes, and STIP1 binds to Hsp70. Recognition of precise processes allows for the invention of effective treatment methods. Potential drugs may either reduce tau levels or inhibit tau accumulation and aggregation. Some substances neuroprotect from Aβ toxicity. Further studies on chaperones and co-chaperones are required to understand the fundamental tenets of this topic more entirely and improve the prevention and treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansMolecular ChaperonesHSP90 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer’s diseaseHsp60Hsp70Hsp90chaperonesclusterindementia

Substanzen

Molecular ChaperonesHSP90 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Faculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, Poland.
  • Clinic of Psychiatry, Department of Psychiatry, Wroclaw Medical University, Ludwika Pasteura 10, 50-367 Wrocław, Poland.

ORCID-Profile: Joanna Batko, Katarzyna Antosz, Weronika Miśków, Magdalena Pszczołowska

Zitieren

APA

Batko, J., Antosz, K., Miśków, W., Pszczołowska, M., Walczak, K., & Leszek, J. (2024). Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease. International Journal of Molecular Sciences, 25(6), 3401. https://doi.org/10.3390/ijms25063401

Vancouver

Batko J, Antosz K, Miśków W, Pszczołowska M, Walczak K, Leszek J. Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease. International Journal of Molecular Sciences. 2024;25(6):3401. doi:10.3390/ijms25063401

BibTeX
@article{Batko2024,
  author = {Batko, Joanna and Antosz, Katarzyna and Miśków, Weronika and Pszczołowska, Magdalena and Walczak, Kamil and Leszek, Jerzy},
  title = {Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {6},
  pages = {3401},
  doi = {10.3390/ijms25063401}
}
Kostenlos starten →